Brise Pharma Announces First Patient Dosed with BR01T in Phase I Study in Patients with Chronic Low Back Pain ...Middle East

News by : (PR Newswire) -
SHANGHAI, Aug. 18, 2023 /PRNewswire/ -- Brise Pharmaceuticals Co., LTD., a pioneering company specializing in innovative treatments for chronic pain, has taken a significant step forward with the commencement of dosing for the initial participants in its Phase 1 clinical trial, designated...

Hence then, the article about brise pharma announces first patient dosed with br01t in phase i study in patients with chronic low back pain was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Brise Pharma Announces First Patient Dosed with BR01T in Phase I Study in Patients with Chronic Low Back Pain )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار